Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 20, 2009 - Issue 1
Submit an article Journal homepage
358
Views
62
CrossRef citations to date
0
Altmetric
THERAPY

The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: A double-blind, placebo-controlled clinical trial

Iraj Esfandiarpour Kerman Medical University, Department of Dermatology, Kerman, IranCorrespondence[email protected]
,
Ali Ekhlasi Kerman Medical University, Department of Dermatology, Kerman, Iran
,
Saeedeh Farajzadeh Kerman Medical University, Department of Dermatology, Kerman, Iran
&
Saadollah Shamsadini Kerman Medical University, Department of Dermatology, Kerman, Iran
Pages 14-18 | Received 06 Jan 2008, Accepted 11 Apr 2008, Published online: 12 Jul 2009

References

  • Ongenae K, Dierckxsens L, Brochez L, vanGeel N, Naeyaert JM. Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage. Dermatology. 2005; 210: 279–85
  • Westerhof W, d'Ischia M. Vitiligo puzzle: The pieces fall in place. Pigment Cell Res. 2007; 20: 345–59
  • Castanedo-Cazares JP, Lepe V, Moncada B. Repigmention of chronic vitiligo lesions following tacrolimus plus ultraviolet-B-narrow-band. Photodermatol Photoimmunol Photomed. 2003; 19: 35–6
  • Lan CC, Chen GS, Chiou MH, Wu CS, Chang CH, Yu HS. FK 506 promotes melanocyte and melanoblast growth and creates a favorable milieu for cell migration via kerationcytes. Br J Dermatol. 2005; 153: 496–505
  • Cui J, Shen LY, Wang GC. Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol. 1991; 97: 410–16
  • Grimes PE. Therapeutic trends for the treatment of vitiligo. Cosmetic Dermatol. 2002; 15: 21–5
  • Ortonne JP, Passeron T. Melanin pigmentary disorders; Treatment update. Dermatol Clin. 2005; 23: 209–26
  • Scherschum L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol. 2001; 44: 999–1003
  • Tjioe M, Gerristen MJ, Juhlin L, Van de kerkhof PC. Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm Venereol. 2002; 82: 369–72
  • Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UVB radiation vs topical psoralen plus UV-A. Arch Dermatol. 1997; 133: 1525–8
  • Kanwar AJ, Dogra S, Parsad D. Topical tacrolimus for treatment of childhood vitiligo in Asians. Clin Exp Dermatol. 2004; 29: 589–92
  • Kawalek AZ, Spencer JM, Phelps RJ. Combined excimer laser and topical tacrolimus for the treatment of vitiligo: A pilot study. Dermatol Surg. 2004; 30: 130–5
  • Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Alvarez MB, Ortiz CA, Torres-Rubalcava AB. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol. 2003; 139: 581–5
  • Silverberg NB, Lin P, Travis L. Tacrolimus ointment promotes repigmentation of vitiligo in children: A review of 57 cases. J Am Acad Dermatol. 2004; 51: 760–6
  • Smith DA, Tofte SJ, Hanifin JM. Repigmentation of vitiligo with topical tacrolimus. Dermatology. 2002; 205: 301–3
  • Fai D, Cassano N, Vena GA. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: A review of 110 patients. J Eur Acad Dermatol Venereol. 2007; 21: 916–20
  • Gupta AK, Chow M. Pimecrolimus a review. J Eur Acad Dermatol Venereol. 2003; 17: 493–503
  • Mayoral FA, Gonzalez C, Shah NS, Arcinigas C. Repigmentation of vitiligo with pimecrolimus cream: A case report. Dermatology. 2003; 207: 322–3
  • Grimes P, Morris R, Aghajani E, Soriano T, Meraz M, Metzger A. Topical tacrolimus therapy for vitiligo: Therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J Am Acad Dermatol. 2004; 51: 52–61
  • Mehrabi D, Pandya AG. A randomized, placebo-controlled, double blind trial comparing narrow-band UV-B plus placebo in the treatment of generalized vitiligo. Arch Dermatol. 2006; 142: 927–9
  • Tran C, Lubbe J, Sorg O, Doelker L, Carraux P, Antille C, et al. Topical calcineurin inhibitors decrease the production of UVB-induced thymine dimers from hairless mouse epidermis. Dermatology. 2005; 211: 341–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.